Tuesday 29 September 2009

Prostate cancer tests from 40,say experts(Australia)

23 September 2009

Australian men should begin routine testing for prostate cancer from age 40 to boost rates of early detection and help to reduce deaths, experts say.

The Urological Society of Australia and New Zealand (USANZ) has reduced the age at which it recommends men have their first Prostate Specific Antigen (PSA) test, by 10 years.

USANZ president Dr David Malouf said the move followed a review of the latest research into the cancer, which is now diagnosed in 10 men under the age of 50 every week in Australia and New Zealand.

"If we continue to wait until men are 50 before being tested, we will miss some with prostate cancer who could have been identified much earlier, monitored by their GPs and urologists and received timely appropriate advice and treatment," Dr Malouf said.

"These men have a better prognosis if they are picked up earlier."The blood test for prostate cancer checks the level of a protein which is otherwise part of a man's ejaculatory fluid.

Elevated levels of this protein in a man's blood indicates the prostate, which produces it, is not working properly, possibly caused by cancer.Men with a PSA level higher than 0.6 at age 40 were considered to be at high risk of developing the cancer, or above 0.7 in men over 50.

"There is now strong evidence that having a baseline PSA test at age 40 is a smart move which can help determine whether a man is in a low risk or high risk category," Dr Malouf said.

USANZ announced its revised PSA test recommendation for Australian men at an event in Sydney.Dr Malouf said there was firm data that PSA testing reduced the risk of men being diagnosed with the cancer in its advanced stage, and that treatment at an early stage reduced the risk of death.

A family history of the cancer can also indicate a man faces a higher risk.

Prostate cancer tests from 40,say experts"

Younger men urged to have prostate cancer test (Australia)

Meredith Griffiths reported this story on Wednesday, September 23, 2009 08:21:00

TONY EASTLEY: Prostate cancer kills more than 3,000 Australian men every year. The conventional wisdom has always been that if there's no family history of the disease, men don't really need to worry about it until after they're 50, but urologists have changed their mind and they now want all men over 40 to be tested.

Meredith Griffiths reports.

MEREDITH GRIFFITHS: When Ross Jefferey was in his early 40s, prostate cancer was far from his mind.

ROSS JEFFEREY: I had a vague awareness about prostate cancer as being something that typically affects old men and you know I knew that in the 50s you should be starting to talk to your doctor about it, but not as a 45, 46 year old, it wasn't on my radar.

MEREDITH GRIFFITHS: So he was shocked when his 46-year-old brother was diagnosed with the disease.

ROSS JEFFEREY: He was going for a knee operation and his GP said, well we'll do the usual round of blood tests beforehand, and amongst that was a PSA test that popped up as being high, and after a biopsy he found himself having an operation to remove his prostate which was found to be cancerous.

MEREDITH GRIFFITHS: PSA is the measure by which doctors gauge a man's risk of getting prostate cancer. Regular blood tests over the next two years showed that Ross Jefferey's PSA levels were getting higher and in 2007 he had surgery to remove cancer.

Dr David Malouf says Mr Jefferey is just one of about 500 men under the age of 50 to be diagnosed with prostate cancer each year in Australia and New Zealand.

DAVID MALOUF: Forty-eight-year-old men dying of prostate cancer, 54-year-old men dying of prostate cancer. We know that those men, if their cancer had been picked up five, 10 or even 15 years earlier the vast majority of those men who are incurable at diagnosis could have been identified earlier, could have been treated and cured.

MEREDITH GRIFFITHS: Dr Malouf is the president of the Urological Society of Australia and New Zealand which is now recommending that men get tested for prostate cancer once they turn 40.

DAVID MALOUF: The age of 50 has been the accepted wisdom for at least 10 or 15 years, but based upon a couple of studies which have matured over the last 12 months, we know that an early PSA test at the age of 40 is a predictor of a man's subsequent risk of prostate cancer.

MEREDITH GRIFFITHS: Men simply have to go to their GPs and Dr Malouf says there's no doubt that changing the policy will save lives.

DAVID MALOUF: For the vast majority of men at 40, their PSA test will be very, very low and they can be reassured that their risk of prostate cancer is low and they can have much lower frequency of testing. However for a small group of men, their PSA will be in a higher range and they will need to be more carefully monitored.

TONY EASTLEY: The president of The Urological Society of Australia and New Zealand, Dr David Malouf, the reporter Meredith Griffiths.

Younger men urged to have prostate cancer test

ICS Annual Meeting 29 Sept - 3rd Oct.

ICS Annual Meeting

Saturday 26 September 2009

(UK)The Prostate Cancer Charity’s first TV commercial

Better late than never:

The Prostate Cancer Charity’s first TV commercial was screened on Saturday night during the coverage of the Tour of Britain highlights on ITV4.

The ad has been developed to help raise awareness of prostate cancer and of The Prostate Cancer Charity’s Helpline which people can contact for information and support. The Charity is extremely happy to have this opportunity, as part of the Tour of Britain partnership, to raise awareness with such a large, well-suited audience. The ITV4 programme is watched by over 300,000 people - mainly men over 40.

BBC sports presenter (former Sheffield Wednesday striker) Mark Bright lent his voice to the advert which uses a ‘stick-man’ to simplify the complexity of the issues surrounding prostate cancer and to help lighten the subject so that men feel comfortable considering and talking about prostate cancer. We certainly hope that it will encourage anyone out there with any concerns to come forward and get in touch with The Prostate Cancer Charity.

Wednesday 23 September 2009

AUGS 30th Annual Scientific Meeting (Updated-26th Sept.)

AUGS 30th Annual Scientific Meeting
September 24-26, 2009

Westin Diplomat Resort, Hollywood, FL

Join AUGS as we celebrate 30 years of Annual Scientific Meetings during the 2009 Annual Scientific Meeting in Hollywood, Florida! Learn the latest from female pelvic medicine and reconstructive surgery experts while taking advantage of multiple networking opportunities with others who share your interest in urogynecology and female urology. From exciting events that support the AUGS Foundation to enriching education sessions, the AUGS 30th Annual Scientific Meeting offers something for everyone!

AUGS 30th Annual Scientific Meeting


Pelvic Floor Disorders Will Impact as Many
as One-Third of All Women in 2050

Tuesday 22 September 2009

NEWS-Week Ending 27th September(Updated-2 Posts)

'Check at 40' for prostate cancer New Zealand-24th September

Carefully weighing the options Canada-22nd September

Johnny Ramone

I never realised that Johnny Ramone died after a five year battle against Prostate Cancer back in 2004:

Johnny Ramone


And the reason for the post:

Johnny Ramone Fans Will Party In The Cemtery
Fans will pay tribute to the late Johnny Ramone by partying in a cemetery next month.

LOS ANGELES (September 21, 2009)--Fans will pay tribute to Johnny Ramone of The Ramones by partying next month in a cemetery.

Tommy and CJ Ramone will be part of the celebration of Johnny's life on Oct. 3 at the Hollywood Forever Cemetery in Los Angeles.

The party includes a showing of the 1977 Ramones concert film "It's Alive" on the mausoleum wall, as well as a screening of Johnny's favorite movie, "Night of the Living Dead."

Proceeds from the event will benefit the Johnny Ramone Research Fund at USC Westside Prostate Cancer Center.

Johnny Ramone Fans Will Party In The Cemtery

Wednesday 16 September 2009

NFL Season Kicks Off with Campaign to “Know Your Stats about Prostate Cancer



While most men might know the stats of their favorite NFL player, they are likely unaware of other important statistics that could one day save their lives. As a result, the American Urological Association (AUA) Foundation and the National Football League (NFL) are teaming to encourage men to “Know Your Stats about Prostate Cancer,” the second leading cause of cancer death for American men. Men and their loved ones can visit www.KnowYourStats.org for information about prostate cancer and where to find free or low-cost screening locations.

One in every six men will be diagnosed with prostate cancer in his lifetime. To fight this deadly disease, the American Urological Association (AUA)has issued new guidelines recommending that men 40 and older talk with their doctors about prostate cancer testing. A physical exam and simple blood test to establish a baseline PSA (prostate-specific antigen) score today could help save a life later.

“We encourage men to be as passionate about their health as they are about their favorite NFL teams and players,” said NFL commissioner Roger Goodell.

The relationship between the AUA Foundation and the NFL began in 2007 when the NFL Player Care Foundation began implementing prostate cancer screenings conducted by the AUA Foundation. The NFL Player Care Foundation was created in 2007 to address health and quality of life issues encountered by retired players.

To promote September’s Prostate Cancer Awareness Month, 27 retired NFL Hall of Fame players recorded a public service announcement to urge men to get tested for prostate cancer. Led by Hall of Famer and prostate cancer survivor Michael Haynes, the message also features football legends, or “Team Haynes” members, including Tony Dorsett, Anthony Munoz, “Mean” Joe Greene, upcoming “Dancing with the Stars” contestant Michael Irvin and more.

Prostate cancer is the most common non-skin cancer in males in the United States, killing more than 28,000 men in 2008. African-American men and men with a family history are at a higher risk for developing prostate cancer, with African-American men more than twice as likely to die from the disease.

“Men should talk with their doctors so they can make informed decisions about prostate cancer testing,” said Robert S. Waldbaum, M.D., F.A.C.S, and AUA Foundation spokesperson. “Knowing your stats empowers patients and their doctors with the facts to make informed decisions.”


NFL great Mike Haynes is one of the many men who have benefitted from early detection due to prostate cancer testing. Before his diagnosis through a free NFL Player Care Foundation screening conducted by the AUA Foundation, prostate cancer was the last thing on Haynes’ mind. Now a prostate cancer survivor, Haynes is speaking out, in partnership with the NFL and the AUA Foundation, encouraging men to talk to their doctors.

“Before I was diagnosed with prostate cancer, I never knew I was at risk for this disease. Now I know how important it is to play defense against prostate cancer and to start getting tested at 40,” says Haynes. “A simple test saved my life.”

The AUA Foundation will continue to work with the NFL Player Care Foundation to screen retired players across the country and encourage fans to get in the game where their health is concerned.

What You Should Know, or Share with the Men in Your Life, About Prostate Cancer:


Prostate defense starts at 40. Talk with your doctor about prostate cancer testing.
o The American Urological Association recommends that men ages 40 and older talk with their doctor about prostate cancer testing including the prostate-specific antigen (PSA) test and a simple physical exam.
o Knowing your score today could help save your life later. Establishing a baseline PSA score at age 40 can help doctors better interpret your future PSA scores.
Know Your Stats – and don’t let prostate cancer take you out of the game. Visit www.knowyourstats.orgto learn more.

About Prostate Cancer
Prostate cancer is most treatable when caught early. The American Urological Association recently revised its guidelines to recommend men get a baseline PSA test at age 40 and talk with their doctors to create a prostate health plan based on lifestyle and family history. The future risk of prostate cancer is closely related to a man’s PSA score, and men who are screened at age 40 establish a baseline score that can be tracked over time.

NFL Season Kicks Off with Campaign to “Know Your Stats about Prostate Cancer

Monday 14 September 2009

NEWS-Week Ending 20th September(Updated-8 posts)

The Japanese Guideline For Prostate Cancer Screening Japan-19th September

Men Diagnosed With Prostate Cancer In Recent Years Have Better Survival Outcomes,Study Shows USA-18th September

"The Depend Campaign to End Prostate Cancer" Brings Sports Legends Together to Celebrate National Prostate Cancer Awareness Month Canada and the USA-17th September

Tour of Britain:Unite by cycling for Prostate Cancer Charity UK-17th September

Prostate cancer ranks as No.1 killer of men in Arizona USA-16th September

Beaches100 hopes to get word out on cancer USA-15th September

Early detection is key to surviving prostate cancer USA-15th September

'Watchful Waiting' Is A Viable Option For Prostate Cancer Patients With Low-risk Tumors, Study Finds USA-14th September

More evidence that deferring treatment can work just fine

Concrete evidence that, for many appropriately selected men, deferred treatment may be a better choice than invasive treatment continues to accumulate. While there is still no category 1 evidence from a large, randomized clinical trial, a newly published article examined data on the management of prostate cancer patients enrolled in the Health Professionals Follow-up Study — a prospective study of 51,529 men.

Shappley et al. calculated the hazard ratios (HRs) for time to eventual treatment among men who deferred treatment for more than 1 year after diagnosis. The HRs for time to metastasis or death as a result of prostate cancer were then compared between patients who deferred treatment and those who underwent immediate treatment within 1 year of diagnosis. The results of their analysis are as follows:

3,331/51,529 cohort participants (6.5 percent) were diagnosed with prostate cancer between 1986 and 2007.

342/3,331 patient (10.3 percent) initially deferred treatment.

174/342 patients who deferred treatment (51 percent) remained untreated throughout follow-up (mean 7.7 years).

168/342 patients who deferred treatment (49 percent) were treated an average of 3.9 years after diagnosis.

Factors associated with progression to treatment among DT patients included younger age, higher clinical stage, higher Gleason score, and higher PSA level at diagnosis.
The rates for development of metastases were similar between the deferred treatment and the early treatment groups.

In the deferred treatment group, 20/342 patients progressed to metastatic disease at a rate of 7.2 per 1,000 person-years.

In the early treatment group, 199/2,989 patients progressed to metastatic disease at a rate of 8.1 per 1,000 person-years.

The rates for prostate cancer-specific death were also similar between the two groups.
In the deferred treatment group, 8/342 patients died of prostate cancer at a rate of 2.4 per 1,000 person-years.

In the early treatment group, 80/2,989 patients died of prostate cancer at a rate of 2.6 per 1,000 person-years.

While this study was not conducted as a randomized trial, and while there was no specific protocol being followed by patients who chose to defer treatment, three clear conclusions can be drawn from this community setting-based, national study:

> 50 percent of the men who opted for deferred treatment went without treatment for 7.7 years after diagnosis.

Older men, and men with lesser cancer severity at diagnosis, were more likely to remain untreated.

Prostate cancer mortality did not differ between patients who received deferred as compared to early forms of treatment.

The “New” Prostate Cancer InfoLink is increasingly convinced that we need national guidelines for both the selection of patients who are suitable for deferral of treatment and for the management of such patients based on their type. Active surveillance of some type certainly seems to be wise for those patients in whom curative intervention may still be needed (i.e., patients who have long life expectancies and with a rising PSA) but more conservative forms of management, with deliberate avoidance of excessive biopsying, may be more suitable for men with shorter life expectancies and early stage, low risk disease.

More evidence that deferring treatment can work just fine

The Impact of Cancer In Cameroon(Updated 16th September)

"February 01, 2009: ARA Champions the fight against Cancer in Cameroon

ARA has signed an agreement with the Cameroon National Cancer Control program to sensitize/educate Cameroonians on Cancer and Cancer prevention, and provide Palliative care to Cancer patients in Cameroon."

"According to the World Health Organization (WHO), a cancer epidemic is brewing in Africa.

There is no cancer treatment available in many regions for the 650,000 documented Africans who develop cancer annually, resulting in about 510,000 deaths —almost 80% of all cancer cases in Africa. By 2020 Africa will account for more than one million new cancer cases a year, and they are the least able of all developing countries to cope, having few cancer care services.

1 Lack of resources and basic infrastructure means that most Africans have no access to cancer screening, early diagnosis, treatment or palliative care.

2 In fact according to the IAEA (International Atomic Energy Agency) millions of cancer victims in developing countries lack access to life-saving radiotherapy and other forms of treatment, with at least $2.5 billion needed to provide adequate treatment facilities, half to purchase machines, and half to train the physicians and physicists required to ensure safe and effective treatment.

Life-saving radiotherapy is available in only 21 of Africa’s 53 countries, or to less than 20% of the population, and consequently cancer is often a sentence to a painful and distressing death. Also, basic, epidemiologic and interventional research are relevant to caring for cancer patients, and each can, at least in principle, be carried out in Africa. Yet research capacity, mentorship and resources are lacking. Even more disheartening is that over one third of cancer deaths are due to preventable causes such as viral infection, poor nutrition and widespread tobacco use. Breast Cancer and Uterine Cancer are the most prevalent in Cameroonin women(about 33% and 24 %, respectively). In men, prostate cancer and liver cancer dominate."



"Cameroon has only two Cancer treatment centers. University of Yaounde I, Cameroon is the leading university in Cameroon and harbors one of the 2 Cancer treatment centers. For a population of over 16 million, one medical physicist, 10 pathologists and 3 cytotechnicians.

Cancer surveillance is not well organized in Cameroon. Most cancer related deaths are neither reported nor recorded. The majority of cancer patients go for consultation only at an advanced stage of the disease. Ignorance, local beliefs and poverty influence the behavior of patients.

Traditional healers, medical and paramedical staff who, for financial or other reasons, insist on treating cancer patients even though they lack the required expertise, thus delay referral to the limited facilities. The limited number of personnel trained in oncology is further compounded by the lack of enthusiasm on the part of young medical officers and nursing staff for oncology. These limiting factors confirm the urgency of getting assistance for the cancer control program in Cameroon by empowering the university of Yaounde I.

The political will to reverse the current trend of affairs is in no doubt. This political commitment is evidenced by the provision for cancer control in the National Health Development Program, its inclusion in the Health Sector Strategy, the re-organization of the National Cancer Control Committee (NCCC) as well as the appointment of its officials."

ARA Champions the fight against Cancer in Cameroon

Prostate Cancer in Cameroon


I have added Cameroon to the main database found under the month of April under the title of Global Health

Europe-Urology Week - organised on 14 and 15 September 2009

- Prostate cancer is the second leading cause of cancer death in Western world.

- Every year 346,000 new cases of prostate cancer are detected in Europe alone.

- More than 50% of men over 50 have urological complaints due to benign conditions.

- Epidemiologic data indicate that erectile dysfunction (ED) is a significant problem among men worldwide. As many as 42.8 million men are expected to suffer from ED in Europe alone in 2025.

Just a few facts about urological conditions, which affect the lives of millions of men and women every day. Shame and undetected symptoms are among the key reasons why many Europeans neglect to seek medical help when experiencing urological complaints. And that is too bad, since often there is help available.

Urology Week - organised on 14 and 15 September 2009 - is a tool with which the European Association of Urology (EAU), the European knowledge centre of urology in Arnhem, wishes to stimulate people over 50 to visit their doctors when they suffer from such complaints..

The EAU has selected prostate conditions and erectile dysfunction to be the key themes of Urology Week. We seek to create more awareness of urological conditions and the work of the urologist among the European public, especially those over 50, since they are the ones who suffer from these conditions most. The organisation cooperates closely with Europa UOMO, a European advocacy movement for the fight against prostate cancer, and other specialist and patient organisations at a European level.

Europe-Urology Week

Sunday 13 September 2009

September-Music/Film Selection(Updated-16th)

Thought I'd inflict some music and film clips that I like,for anyone reading this blog.I'll make it a monthly event so be warned-lol.

Clasical

Joan Sutherland sings The Bohemian Girl


Blues

Big Bill Broonzy Live 1956 Part 1

Big Bill Broonzy Live 1956 Part 2


Bluegrass/folk

David Holt and Doc Watson: Shady Grove

A clip from a festival that's sadly no more:
Edale Blugrass Festival 94

Popular

The Velvet Undergound & Nico - Femme Fatale

Films

dr. strangelove-survival plan

PCRI holds annual prostate cancer gathering

Over 600 attendees gathered in Los Angeles at the annual educational forum of the Prostate Cancer Research Institute (PCRI) this weekend to hear from a broad spectrum of speakers on current trends in research and clinical practice.

The meeting moderator, Mark Moyad, MD, from the University of Michigan, was somewhat distracted by a critical season-opening football game — but was smiling broadly by the time he delivered his highly entertaining but still serious address at the gala dinner on Saturday night.

There were a number of excellent presentation during the course of Saturday, particularly by David Heber, MD, of the UCLA Center for Human Nutrition (”Inhibiting cancer with diet”), John Mulhall, MD, of Memorial Sloan-Kettering Cancer Center (”Erectile dysfunction”), and Charles “Snuffy” Myers, MD (”Second line hormone blockade”). Drs. Mulhall and Myers must have answered hundreds of questions from individual attendees before the day was done.

At the gala dinner, the second annual Harry Pinchot Award was given to Lyle LaRoach, the president of the Informed Prostate Cancer Support Group (IPCSG) in San Diego. Lyle expressed his great honor at being only the second recipient of this award, and expressed the hope that this would help to give added stature to the IPCSG across San Diego County.

Prostate Cancer International has been working with PCRI at this meeting to expand its initial series of brief video interviews, Let’s Talk About Prostate Cancer, and PCRI has itself been recording all of the presentations given by faculty at this meeting. We hope to have all materials up on line within a few weeks.

PCRI holds annual prostate cancer gathering

Thursday 10 September 2009

Prostate Cancer Mission 2009 Open Conversation(Updated-12th September

"Why Should I Have a PSA?"


Find more videos like this on The "New" Prostate Cancer InfoLink Social Network


Why Should I Have a PSA?







I think this took place in May 2009 and is well worth viewing:


Find more videos like this on The "New" Prostate Cancer InfoLink Social Network

ZERO provides US prostate cancer policy update

Thanks to 'The "New" Prostate Cancer InfoLink' for highlighting this:

Posted on September 9, 2009 by Sitemaster

Skip Lockwood of ZERO — The Project to End Prostate Cancer has today provided an update on the many prostate cancer issues that the US Congress has been and will be working on as the fiscal year and the 2009 legislative cycle draw to a close.

Thomas J. Manton Early Detection and Treatment Act]

Congressman Jim Marshall (GA) is determined this year to introduce this bill, which is designed to provide early detection and treatment of prostate cancer for under-insured and uninsured men, similar to the breast and ovarian cancer program at the U.S. Centers for Disease Control.

Rep. Marshall has delayed introduction of the bill in hopes of securing initial support from the entire New York congressional delegation, as the late Rep. Manton came from New York. The New York delegation, however, includes a number of new members who are unfamiliar with the bill and have been reluctant to sign on as original co-sponsors.

ZERO continues to work with Rep. Marshall and his staff to educate them and ease any concerns about a variety of scientific data generated this year on the early detection of prostate cancer and its potential impacts.

ZERO provides US prostate cancer policy update



Monday 7 September 2009

Survivor urges men to look out for prostate cancer(UK)

Wednesday, September 02, 2009

"AN ELECTRICIAN diagnosed with prostate cancer at just 41 years old has urged other men to watch out for the disease's symptoms.
Ian Lidstone, of Trematon near Saltash, said he was lucky the cancer was discovered before it spread through his body."

"The youngest member of the Derriford Prostate Support Group, he said he had decided to tell his story to The Herald in order to raise awareness of the condition.
"Younger men need to be more aware of prostate cancer," he said. "In the pamphlets, it's all old people with beards and gloves, but there must be younger men out there walking around with it."

"The only symptom of prostate cancer Ian experienced was feeling the need to pass urine more often at night, but often being unable to do so. At first dismissing it as merely a sign of getting older, he waited six weeks before taking the problem to his GP, in September last year. Initial tests showed nothing abnormal, but a PSA (prostate- specific antigen) screening test suggested otherwise.
Ian's PSA level was 56, when healthy levels are usually less than four. He was referred for a biopsy at Derriford Hospital."

Survivor urges men to look out for prostate cancer

Thursday 3 September 2009

Mediwatch-Urodynamics Training courses

The initial second wave of training courses planned for September and December have been increased to include a date in October (see original post in July).The September course started today 3rd-4th September 2009.

Urodynamics Training courses

Fundamentals of Urodynamics Workshop

September-October-December

Urodynamics Training courses PDF

USA Support/Service

Australia-September Awareness - Blue Events(Updated 14th Sep)

Between September 7-11, Parliament House, Canberra, turned blue to acknowledge the efforts of PCFA in creating awareness towards men's health during Prostate Cancer Awareness Month.




The Big Merino in Goulburn is going blue on September 10 to support International Prostate Cancer Awareness Month.




On September 1, the Swan Bell Tower, Perth, turned blue for the launch of International Prostate Cancer Awareness Month in WA.




On September 1, the Commonwealth Bank building in Sydney turned blue to mark support of International
Prostate Cancer Awareness Month.





On September 1, the Sydney Opera House turned blue to launch International Prostate Cancer Awareness Month.



Prostate Cancer Awareness Month

Tuesday 1 September 2009

(Australia)Bell Tower turns blue for prostate cancer

Almost 2000 WA men are diagnosed with prostate cancer every year, yet it is one of the least talked-about cancers.

In a bid to change that, Perth's Bell Tower turned blue tonight to mark the start of International Prostate Cancer Awareness Month.



Survivors and medical professionals were among those who turned out to support Perth Prostate Cancer Foundation's month of events and initiatives to increase knowledge of the disease in WA.

People are being encouraged to dress in blue or hold a barbecue this month to raise funds for the Prostate Cancer Foundation of Australia.

Supporters can also buy $6 pair of blue laces throughout September in aid of the charity ahead of Blue Laces Day on September 18.

Bell Tower turns blue for prostate cancer

FUTURE EVENTS AND LATEST NEWS(Updated 3rd Sept.)

Director Dealings Mediwatch-3rd September

Director Dealings Mediwatch-2nd September

Mediwatch Plc Investor Day-Monday 7th September

AUGS 30th Annual Scientific Meeting USA-24th-26th September

International Continence Society Annual Meeting USA-29th September to 3rd October


STUFF THAT MAYBE DID BUT NOW
DOESN'T FIT IN WITH THE TITLE...


Mediwatch Interim Results for the six month ended 30 April 2009

Five year global distribution agreement secured with Inverness Medical Innovations-16 March 2009

Preliminary Results for the year ended 31 October 2008-Issued 26 January 2009




Urology in September

Mediwatch Plc Investor Day-Monday 7th September


PROSTATE CANCER AWARENESS WEEK (PCAW)-September 20th-26th 2009

September Is National Prostate Cancer Awareness Month USA-27th August



Australia

September is Prostate Cancer Awareness Month




September is Prostate Cancer Awareness Month and we are asking Australia to get involved and help create awareness and raise the much needed funds to help in the fight against prostate cancer. Prostate cancer is the most common cancer in Australia with 20,000 men diagnosed and close to 3,300 deaths each year. By hosting a barbecue and asking guests to make a donation, Australians can make a significant impact in the fight against this disease. A barbecue is also an ideal opportunity to raise awareness about prostate cancer. Further information on how to host a BBQ and fundraise for PCFA will be posted to the website on August 12.

The Prostate Cancer Foundation of Australia


It is also worth pointing out that Mediwatch made the following statement within their recent Interim Results:

"Negotiating 1,000 patient trial for PSAwatch system in Australia - due to start September 2009"

Obviously time will tell if there is a link..........




Europe

Urology Week - organised on 14th and 15th September 2009


- Prostate cancer is the second leading cause of cancer death in Western world.
- Every year 346,000 new cases of prostate cancer are detected in Europe alone.
- More than 50% of men over 50 have urological complaints due to benign conditions.
- Epidemiologic data indicate that erectile dysfunction (ED) is a significant problem among men worldwide. As many as 42.8 million men are expected to suffer from ED in Europe alone in 2025.


"Urology Week - organised on 14 and 15 September 2009 - is a tool with which the European Association of Urology (EAU), the European knowledge centre of urology in Arnhem, wishes to stimulate people over 50 to visit their doctors when they suffer from such complaints..

The EAU has selected prostate conditions and erectile dysfunction to be the key themes of Urology Week. We seek to create more awareness of urological conditions and the work of the urologist among the European public, especially those over 50, since they are the ones who suffer from these conditions most. The organisation cooperates closely with Europa UOMO, a European advocacy movement for the fight against prostate cancer, and other specialist and patient organisations at a European level.

This Urology Week website offers the latest information about prostate conditions and erectile dysfunction. If you suffer from any of these, do not wait. Contact a specialist; visit your urologist."

Urology Week Website


A very informative and interesting interview with Professor Abrahamsson,the EAU Secretary General relating to 'Urology Week' and erectile dysfunction specific:

Professor Abrahamsson-Interview



USA

AUGS 30th Annual Scientific Meeting-Florida,September 24th- 26th,2009


It's worth noting firstly Mediwatch's Priority points for this event along with the companies they are associated with or in partnership with:

Bard,Inverness Medical Innovations Inc,Society of Urological Nurses and Associates & T-Doc


2009 Exhibitors

Exhibitor Priority Points




USA






ICS 2009 Scientific Programme Tuesday 29th to Saturday 3rd October 2009



It is a great honour to welcome you to the ICS Annual Meeting in San Francisco from September 29th to October 3rd, 2009. This will be the first time in 10 years that the meeting has been held in the USA, and it is most fitting that our society has chosen this vibrant, diverse and beautiful city to host this event.

Welcome to the ICS Website